The Nanomedicine Lab’s mission is to:
Generate and disseminate fundamental knowledge in the emerging field of nanomedicine by bringing together bioengineering, pharmacology and nanotechnology and their translation to advanced, clinically-relevant therapeutics and diagnostics.
Our aim is the development of novel, viable and effective therapeutics based on bioengineering and nanotechnology components, used as either the ‘drug’ or the ‘delivery system’. Such components include DNA, RNA, viruses, stem cells, radionuclides, liposomes, carbon nanomaterials and other nanomaterials (quantum dots, fullerenes, carbon nanohorns).
The research efforts taking place within the Nanomedicine Lab are bridging the gap between fundamental nanomaterials engineering and pharmaceutical development towards the realisation of advanced therapeutic modalities. Our mission is to pioneer the cutting-edge and emerging discipline of nanomedicine.